PYPD PolyPid Ltd Forecast, Technical & Fundamental Analysis

a clinical stage biopharmaceutical company focusing on the development, manufacture, and commercialization of administered therapies to improve surgical outcomes

Industry Biotechnology

Get AI intraday signals

View a ticker or compare two or three

Compare

Ad is loading...

A.I. Advisor

published Earnings

PYPD is expected to report earnings to fall 6.56% to -113 cents per share on February 05

Q4'24

Est.

$-1.14

Q3'24

Missed

by $0.22

Q2'24

Beat

by $0.05

Q1'24

Beat

by $2.78

Q4'23

Missed

by $0.39

The last earnings report on November 13 showed earnings per share of -122 cents, missing the estimate of -100 cents. With 19.09K shares outstanding, the current market capitalization sits at 19.54M.

A.I. Advisor

published General Information

General Information

a clinical stage biopharmaceutical company focusing on the development, manufacture, and commercialization of administered therapies to improve surgical outcomes

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

18 Hasivim Street

Phone

+972 747195700

Employees

Web

https://www.polypid.com

Interesting Tickers

STOCK / NAME	Price $	Chg $	Chg %
		1 Day
GME	31.26	1.82	+6.18%
GameStop Corp
TSLA	479.86	16.84	+3.64%
Tesla
AAPL	253.48	2.44	+0.97%
Apple
BTC.X	106140.600000	110.890625	+0.10%
Bitcoin cryptocurrency
SPY	604.29	-2.50	-0.41%
SPDR® S&P 500® ETF Trust

PYPD and Stocks

Correlation & Price change

A.I.dvisor tells us that PYPD and ELEV have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PYPD and ELEV's prices will move in lockstep.

Ticker / NAME	Correlation To PYPD	1D Price Change %
PYPD	100%	+2.88%
ELEV - PYPD	30% Poorly correlated	+4.66%
ASPHF - PYPD	24% Poorly correlated	N/A
TENX - PYPD	23% Poorly correlated	-0.51%
HOTH - PYPD	22% Poorly correlated	+1.22%
VCNX - PYPD	22% Poorly correlated	-61.37%
More